Iodide

Iodide

SCHEMBL3434472

C=CC[N+](C)(C)c1ccccc1.[I-]

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ ACHE known ✓ P22303 10/20 0.58
▸ BCHE P06276 2/20 0.50
▸ APOBEC3A P31941 1/20 0.46
▸ APOBEC3G Q9HC16 1/20 0.46
▸ ALDH1A1 P00352 2/20 0.41
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPK1 P28482 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ CHRM2 P08172 1/20 0.34
▸ CHRNA7 P36544 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8756173 0.98 ACHE (0.59) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
Bromide SCHEMBL6956206 0.96 ACHE (0.62) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
Hydrochloric Acid SCHEMBL716655 0.96 ACHE (0.58) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL7898036 0.80 ACHE (0.46) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL9327504 0.78 ACHE (0.42) ACHEBCHEALDH1A1MAPK1SMN1; SMN2
Iodide SCHEMBL29602377 0.76 ACHE (0.40) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
Hydrochloric Acid SCHEMBL27711002 0.75 ACHE (0.54) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
Hydrochloric Acid SCHEMBL4903472 0.75 ACHE (0.51) ACHEBCHEALDH1A1CYP1A2CYP2D6
SCHEMBL27047852 0.75 ACHE (0.42) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1
Iodide SCHEMBL11335491 0.75 ALDH1A1 (0.44) ACHEBCHEAPOBEC3AAPOBEC3GALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004202-A1 Quaternary ammonium-functionalized-POSS compounds NDSU RESEARCH FOUNDATION 2010-01-07 — — US disclosed
EP-0251577-B1 Ammonium salt solution as electrolyte for electrolytic capacitors MITSUBISHI PETROCHEMICAL CO (JP) 1994-05-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004202-A1 Quaternary ammonium-functionalized-POSS compounds ARG1, SAE1, RBX1 ACHE 1569/4885BCHE 3970/4885APOBEC3A 3236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback